Melle Holwerda

Melle Holwerda is a dedicated researcher in the field of Virology & Molecular Biology, affiliated with Wageningen University & Research under the Faculty of Veterinary Medicine. Their work primarily focuses on emerging and vector-borne viral diseases affecting ruminants and domestic animals, with a strong emphasis on bluetongue virus (BTV), epizootic hemorrhagic disease virus (EHDV), and zoonotic pathogens like European bat lyssavirus and Japanese encephalitis virus.

Their research interests span virology, molecular diagnostics, infectious disease surveillance, and veterinary public health. Holwerda plays a pivotal role in national and European preparedness for animal disease outbreaks, contributing to diagnostic alignment and vaccine development efforts. Much of their recent work involves field studies on BTV serotypes 3, 8, and 12 in cattle and sheep farms across the Netherlands.

Recent publications highlight a trend toward applied veterinary virology, combining molecular techniques like real-time PCR with epidemiological field data to understand transmission dynamics, clinical manifestations, and within-herd prevalence. Their articles frequently appear in high-impact journals such as Eurosurveillance, Veterinary Microbiology, and Transboundary and Emerging Diseases, often in collaboration with national animal health institutes.

• Scientific Awards: No specific awards mentioned in the provided text.

As a project leader, Melle Holwerda oversees several active research initiatives, including BTV-VesselOnChip, Spidvac (Horizon Europe), and long-term studies on viral zoonoses and vector-borne diseases. They are also a recognized expert in the media, regularly providing commentary on bluetongue outbreaks and vaccination strategies in national outlets such as RTL Nieuws. While no formal students are listed, their leadership in multi-institutional projects suggests mentorship and team coordination roles.

Key research teams and labs include the Virology & Molecular Biology group at Wageningen Bioveterinary Research, with collaborations extending to Royal GD and international partners across Europe.